GoodRx Holdings (GDRX) Acquisitions (2020 - 2025)

GoodRx Holdings has disclosed Acquisitions across 4 years of filings, most recently posting $13.4 million for Q4 2025.

• Acquisitions for Q4 2025 came in at $13.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $13.4 million (down 55.2% YoY), and the FY2025 annual result was $43.4 million, changed N/A from the prior year.
• Acquisitions came in at $13.4 million for Q4 2025 at GoodRx Holdings, down from $30.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $149.9 million in Q2 2022 to a low of $7.0 million in Q1 2022.
• The 3-year median for Acquisitions is $22.3 million (2021), against an average of $56.8 million.
• Across the five-year window, Acquisitions tumbled 73.94% in 2021 and climbed 19.21% in 2022, its largest moves.
• GoodRx Holdings' Acquisitions stood at $14.5 million in 2021, then jumped by 930.79% to $149.9 million in 2022, then tumbled by 91.03% to $13.4 million in 2025.
• The last three Acquisitions figures came in at $13.4 million (Q4 2025), $30.0 million (Q1 2025), and $149.9 million (Q2 2022), per Business Quant data.